paricalcitol capsules

DRUG2 trials

Sponsors

Abbott

Conditions

DialysisEnd Stage Renal DiseaseSecondary Hyperparathyroidism

Phase 3

A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis

CompletedNCT00646035

AbbottEnd Stage Renal Disease

Start: 2002-01-31Updated: 2008-03-28

Phase 4

Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis

CompletedNCT00537979

AbbottDialysis, Secondary Hyperparathyroidism

Start: 2007-09-30End: 2010-07-31Updated: 2011-10-25